Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
Christopher N Hurt, Somnath Mukherjee, John Bridgewater, et al.
The Lancet. Oncology
|
April 30, 2013
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
Thomas Crosby, Christopher N Hurt, Stephen Falk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 15, 2018
External validation of a prognostic model incorporating quantitative PET image features in oesophageal cancer
Kieran G Foley, Zhenwei Shi, Philip Whybra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy
Victoria A Harris, John Staffurth, Olivia Naismith, et al.
Clinical Genitourinary Cancer
|
May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
BMJ Open
|
December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol
Emma Clark, Miranda Morton, Shriya Sharma, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 12, 2022
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
Alison Tree, Clare Griffin, Isabel Syndikus, et al.
The Lancet. Gastroenterology & Hepatology
|
February 21, 2021
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
Douglas Adamson, Anthony Byrne, Catharine Porter, et al.
Health Technology Assessment (Winchester, England)
|
May 27, 2021
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT
Douglas Adamson, Jane Blazeby, Catharine Porter, et al.
Trials
|
August 19, 2021
Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study
Emily Day, A Toby Prevost, Matthew R Sydes, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
Christopher N Hurt, Somnath Mukherjee, John Bridgewater, et al.
The Lancet. Oncology
|
April 30, 2013
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
Thomas Crosby, Christopher N Hurt, Stephen Falk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 15, 2018
External validation of a prognostic model incorporating quantitative PET image features in oesophageal cancer
Kieran G Foley, Zhenwei Shi, Philip Whybra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy
Victoria A Harris, John Staffurth, Olivia Naismith, et al.
Clinical Genitourinary Cancer
|
May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
BMJ Open
|
December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol
Emma Clark, Miranda Morton, Shriya Sharma, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 12, 2022
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
Alison Tree, Clare Griffin, Isabel Syndikus, et al.
The Lancet. Gastroenterology & Hepatology
|
February 21, 2021
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
Douglas Adamson, Anthony Byrne, Catharine Porter, et al.
Health Technology Assessment (Winchester, England)
|
May 27, 2021
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT
Douglas Adamson, Jane Blazeby, Catharine Porter, et al.
Trials
|
August 19, 2021
Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study
Emily Day, A Toby Prevost, Matthew R Sydes, et al.
Page
of 9